Getein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care testing (POCT), clinical chemistry, chemiluminescent assays, hematology, coagulation, urinalysis and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. We also manufacture analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics.
Getein FSH Fast Test Kit is used for women suspected of having polycystic ovary syndrome, and in individuals undergoing evaluation for infertility, also used for evaluation of individuals with suspected pituitary disorders or diseases of the ovaries.
Getein PRL Fast Test Kit is used as an aid in the diagnosis of male and female infertility and pituitary dysfunction, monitoring of male and female gonadal disorders and management of amenorrhea and galactorrhea.
Getein AMH Fast Test Kit is used as an aid in indicating ovarian functional reserve, and also help to diagnose menstrual disorders or to monitor the health of women.
Getein LH Fast Test Kit is used to determine menopause, pinpoint ovulation and monitor endocrine therapy.
Getein HCG+β Fast Test Kit is used as an aid in pregnancy test.
Getein Prog Fast Test Kit is used to measure ovarian function and can determine if a woman has ovulated and when the ovulation occurred.